[1]林印胜,陈 梅,郭坚东,等.Viabahn覆膜支架与旁路途径治疗下肢动脉硬化闭塞症有效性的系统评价及Meta分析[J].介入放射学杂志,2023,32(08):774-781.
 LIN Yinsheng,CHEN Mei,GUO Jiandong,et al.Viabahn covered-stent and bypass approach for the treatment of lower extremity arteriosclerosis obliterans: a systematic review and meta-analysis of its effectiveness[J].journal interventional radiology,2023,32(08):774-781.
点击复制

Viabahn覆膜支架与旁路途径治疗下肢动脉硬化闭塞症有效性的系统评价及Meta分析()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
32
期数:
2023年08
页码:
774-781
栏目:
临床研究
出版日期:
2023-08-29

文章信息/Info

Title:
Viabahn covered-stent and bypass approach for the treatment of lower extremity arteriosclerosis obliterans: a systematic review and meta-analysis of its effectiveness
作者:
林印胜 陈 梅 郭坚东 伍思意 张 艳 李承志
Author(s):
LIN Yinsheng CHEN Mei GUO Jiandong WU Siyi ZHANG Yan LI Chengzhi.
Department of Interventional Radiology and Vascular Surgery, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province 510630, China
关键词:
【关键词】 下肢动脉硬化闭塞症 肝素涂层覆膜支架 旁路途径 有效性 Meta分析
文献标志码:
A
摘要:
【摘要】 目的 系统评价Viabahn覆膜支架与以人工血管为移植物的旁路途径治疗下肢动脉硬化闭塞症的有效性,并且探讨不同直径的Viabahn覆膜支架对股浅动脉通畅率的影响。方法 检索数据库包括万方数据知识平台、中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBM)、EmBase、Cochrane Library和PubMed上有关肝素涂层覆膜支架治疗下肢动脉硬化闭塞症的临床研究。文献检索时间及语言无限制,文献筛选、质量评估、数据提取至少由2位研究者独立完成并交叉核对,采用Cochrane软件和RevMan 5.3软件完成结果分析。结果 纳入文献共10篇(对照研究7篇、非对照研究3篇),肝素涂层覆膜支架与旁路途径疗效对比研究7篇,不同肝素涂层覆膜支架直径疗效对比研究5篇。肝素涂层支架组(Viabahn组)患者792例,旁路途经组(Bypass组)患者299例,Viabahn组行不同支架直径亚组分析(a组:5 mm、b组:6 mm、c组:7 mm),a、b、c组分别有61例、474例、84例患者。Bypass组不仅一期通畅率优于Viabahn组[OR 0.47(0.23,0.94),P=0.03],而且技术成功率更高[RR 0.97(0.94,1.00),P=0.02],但是Bypass组的住院时间明显长于Viabahn组[MD-4.89(-5.29,-4.48),P<0.000 01],两组在截肢率及二期通畅率上没有统计学差异(P>0.05)。a组与b组通畅率没有统计学差异[OR 0.63(0.31,1.28),P=0.20],c组的通畅率要优于b组[(OR 0.57(0.33,0.98),P=0.04]。结论 与Viabahn相比,以人工血管作为移植物的旁路途经具有更好的一期通畅率及技术成功率,但是需要更长的住院时间;推荐置入7 mm直径的Viabahn会得到更高的通畅率,但是需要根据患者实际血管直径来选择。

参考文献/References:

[1] Gerhard- Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American college of cardiology/American heart association task force on clinical practice guidelines[J]. Circulation, 2017, 135: e686- e725.
[2] Conte MS,Bradbury AW,Kolh P,et al. Global vascular guidelines on the management of chronic limb- threatening ischemia[J]. J Vasc Surg,2019,69:3S- 125S.e40.
[3] Ohki T, Kichikawa K, Yokoi H, et al. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions[J]. J Vasc Surg, 2017, 66: 130- 142.e1.
[4] Kruse RR, Poelmann FB, Doomernik D, et al. Five- year outcome of self- expanding covered stents for superficial femoral artery occlusive disease and an analysis of factors predicting failure[J]. J Endovasc Ther, 2015, 22: 855- 861.
[5] Jebran AF, Popov AF, Zenker D, et al. Is there an alternative to the surgical above- knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft[J]. Vasc Endovascular Surg, 2013, 47: 502- 506.
[6] Lepantalo M, Laurila K, Roth WD, et al. PTFE bypass or thrupass for superficial femoral artery occlusion? A randomised controlled trial[J]. Eur J Vasc Endovasc Surg, 2009, 37: 578- 584.
[7] McQuade K, Gable D, Pearl G, et al. Four- year randomized prospective comparison of percutaneous ePTFE/nitinol self- expanding stent graft versus prosthetic femoral- popliteal bypass in the treatment of superficial femoral artery occlusive disease[J]. J Vasc Surg, 2010, 52: 584- 590.
[8] Reijnen MMPJ, Van Walraven LA, Fritschy WM, et al. 1- year results of a multicenter randomized controlled trial comparing heparin- bonded endoluminal to femoropopliteal bypass[J]. JACC Cardiovasc Interv, 2017, 10: 2320- 2331.
[9] Saxon RR, Chervu A, Jones PA, et al. Heparin- bonded, expanded polytetrafluoroethylene- lined stent graft in the treatment of femoropopliteal artery disease: 1- year results of the VIPER (Viabahn endoprosthesis with heparin bioactive surface in the treatment of superficial femoral artery obstructive eisease)trial[J]. J Vasc Interv Radiol, 2013, 24:165- 173.
[10] Schneider JR, Verta MJ, Alonzo MJ, et al. Results with Viabahn- assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease[J]. Vasc Endovascular Surg, 2011, 45: 391- 397.
[11] Waezi N,Saha S,Bougioukas I,et al. Viabahn stent graft compared with prosthetic surgical above- knee bypass in treatment of superficial femoral artery disease: long- term results of a retrospective analysis[J]. Medicine(Baltimore), 2018, 97: e12449.
[12] 宋庆宏,李阳春,赵 奇,等. VIABAHN支架治疗下肢动脉闭塞的效果分析[J]. 天津医药, 2014, 42:825- 826, 827.
[13] Antoniou GA, Chalmers N, Georgiadis GS, et al. A meta- analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease[J]. J Vasc Surg, 2013, 57: 242- 253.
[14] Bohme T, Noory E, Brechtel K, et al. Heparin- bonded stent- graft for the treatment of TASC II C and D femoropopliteal lesions: 36- month results of the viabahn 25 cm trial[J]. J Endovasc Ther, 2021, 28: 222- 228.
[15] Mohr PJ, Oyama JK, Luu JT, et al. Clinical outcomes of endovascular treatment of TASC- Ⅱ C and D femoropopliteal lesions with the Viabahn endoprosthesis[J]. Cardiovasc Revasc Med, 2015, 16: 465- 468.
[16] Uhl C, Dadras A, Reichmann F, et al. Long- term results of the heparin- bonded Viabahn stent graft in femoropopliteal TASC C and D lesions with a covered stent length of minimum 25 cm[J]. Vascular, 2019, 27: 553- 559.
[17] 刘文导,冯柳迁,孟凡喆,等. 下肢动脉硬化闭塞症介入治疗效果及影响术后复发因素分析[J]. 介入放射学杂志, 2017, 26:514- 517.
[18] 贾中芝. 股腘动脉狭窄/闭塞性病变腔内介入治疗[J]. 介入放射学杂志, 2018, 27:598- 601.
[19] 王 宁,刘兆玉.膝下动脉硬化闭塞症介入治疗新进展[J]. 介入放射学杂志, 2017, 26:188- 192.

相似文献/References:

[1]吴晓萍,宋 杰,蒋天鹏,等. 下肢动脉硬化闭塞症血管内治疗的护理[J].介入放射学杂志,2012,(08):685.
 WU Xiao- ping,SONG Jie,JIANG Tian- peng,et al. Nursing care for patients with lower limb arteriosclerosis obliterans receiving endovascular treatment[J].journal interventional radiology,2012,(08):685.
[2]刘文导,冯柳迁,孟凡喆,等.下肢动脉硬化闭塞症介入治疗效果及影响术后复发因素分析 [J].介入放射学杂志,2017,(06):514.
 LIU Wendao,FENG Liuqian,MENG Fanzhe,et al.Curative effect of interventional therapy for arteriosclerosis obliterans of lower extremity and analysis of recurrence factors[J].journal interventional radiology,2017,(08):514.
[3]杨硕菲,张 岚.膝下动脉闭塞腔内治疗热点问题——实践与思考[J].介入放射学杂志,2017,(06):481.
 YANG Shuofei,ZHANG Lan.Endovascular treatment of infrapopliteal artery occlusion: clinical practice and thinking of present hot issues[J].journal interventional radiology,2017,(08):481.
[4]魏恒乐,彭新桂,陆照璇,等.能谱CT最佳单能量成像技术降低下肢动脉成像对比剂用量的可行性 [J].介入放射学杂志,2017,(11):983.
 WEI Hengle,PENG Xingui,LU Zhaoxuan,et al.Application of gemstone optimal monochromatic imaging technique in reducing the amount of contrast agent for lower extremity angiography: a clinical feasibility study[J].journal interventional radiology,2017,(08):983.
[5]柏志斌,秦永林,赵国峰,等.CHA2DS2- VASc评分对下肢动脉硬化闭塞症患者介入治疗后复发风险的预测作用 [J].介入放射学杂志,2019,28(02):184.
 BAI Zhibin,QIN Yonglin,ZHAO Guofeng,et al.Predictive value of CHA2DS2- VASc score for the risk of recurrence in patients with arteriosclerosis obliterans of lower extremities after interventional therapy[J].journal interventional radiology,2019,28(08):184.
[6]谷涌泉,张成超.血管减容联合药物涂层球囊在下肢动脉硬化闭塞病变治疗中的应用[J].介入放射学杂志,2020,29(06):636.
 GU Yongquan,ZHANG Chengchao..Application of vascular volume reduction combined with drug- coated balloon dilation for arteriosclerosis obliterans disease of lower extremities[J].journal interventional radiology,2020,29(08):636.
[7]杜自忠,王 晨,张明星,等.下肢动脉硬化闭塞症患者介入治疗后血清miR-342-5p水平及其意义[J].介入放射学杂志,2020,29(09):894.
 DU Zizhong,WANG Chen,ZHANG Mingxin,et al.Serum level of miR-342-5p and its clinical significance in patients with arteriosclerosis obliterans of lower extremity after interventional therapy[J].journal interventional radiology,2020,29(08):894.
[8]尹 晶,吴清华,王 鹏,等.下肢动脉硬化闭塞症患者介入术后白细胞介素- 8、白细胞介素- 18、血管内皮细胞生长因子检测及意义[J].介入放射学杂志,2021,30(02):132.
 YIN Jing,WU Qinghua,WANG Peng,et al.Detection and significance of interleukin-8, interleukin-18 and vascular endothelial growth factor in patients with lower extremity atherosclerotic occlusion after interventional treatment[J].journal interventional radiology,2021,30(08):132.
[9]高 龙,赵育芳,闫怡舟,等.股浅动脉支架成形术后迟发假性动脉瘤1例 [J].介入放射学杂志,2022,31(12):1221.
 GAO Long,ZHAO Yufang,YAN Yizhou,et al.Late-onset pseudoaneurysm after superficial femoral artery angioplasty: report of one case[J].journal interventional radiology,2022,31(08):1221.
[10]逯 莹,甘红艳,袁艳艳,等.下肢动脉硬化闭塞症介入术后患者运动康复依从性影响因素研究现状[J].介入放射学杂志,2023,32(03):288.
 LU Ying,GAN Hongyan,YUAN Yanyan,et al.Research status in the factors affecting exercise compliance in patients with arteriosclerosis obliterans of lower limbs after interventional treatment[J].journal interventional radiology,2023,32(08):288.

备注/Memo

备注/Memo:
(收稿日期:2022- 06- 19)
(本文编辑:茹 实)
更新日期/Last Update: 2023-08-29